Gibson Dunn has advised Amazon.com, Inc. Davis Polk has advised Barclays Bank PLC, HSBC Bank plc, J.P. Morgan Securities plc, and NatWest Markets Plc as representatives...
Amazon.com Inaugural £4.25 Billion Sterling Notes Offering
Amazon Completes $52 Billion Notes Offerings in USD and EUR Tranches
Gibson Dunn has advised Amazon. Davis Polk has advised the representatives of the underwriters. Amazon.com, Inc. has announced the closing of concurrent SEC-registered notes offerings totaling...
Planet Labs Completes $460 Million Convertible Senior Notes Offering
Wilson Sonsini Goodrich & Rosati has advised Planet Labs, while Davis Polk has advised the representatives of the initial purchasers and the counterparties to the capped...
Zscaler Completes $1.725 Billion Convertible Senior Notes Offering and Capped Call Transactions
Wilson Sonsini Goodrich & Rosati has advised Zscaler, Inc. on the transaction, and Davis Polk has advised the representatives of the initial purchasers and the counterparties...
Netflix’s $1.8 Billion Senior Unsecured Notes Offering
Wilson Sonsini Goodrich & Rosati advised Netflix on the transaction, and Davis Polk & Wardwell advised the underwriters. Netflix, Inc. (Nasdaq: NFLX) completed its inaugural investment...
CSG Systems International’s $425 Million Convertible Senior Notes Offering
Simpson Thacher & Bartlett advised CSG Systems International, Inc., and Davis Polk & Wardwell advised the representatives of the initial purchasers on the offering. CSG Systems...
ACELYRIN’s $621 Million Initial Public Offering
Cooley advised ACELYRIN, and Davis Polk advised the joint book-running managers. ACELYRIN, INC. announced its upsized initial public offering of 34,500,000 shares of common stock at...
Revolution Medicines’ $345 Million Common Stock Public Offering
Latham & Watkins is advising Revolution Medicines on the offering, and Davis Polk is advising the underwriters involved. Revolution Medicines, Inc. (Nasdaq: RVMD) has announced the...
Natera’s $400 Million Shares Offering
Davis Polk advised the representatives of the several underwriters in the offering. Natera, Inc. announced its follow-on offering of 11,430,000 shares of common stock for total gross...
Tenaya Therapeutics’ $75 Million Shares Offering
Wilson Sonsini Goodrich & Rosati advised Tenaya on the deal, while Davis Polk advised the joint book-running managers and representatives of the several underwriters. Clinical stage...
IDEAYA Biosciences’ $80 Million Common Stock Offering
Latham & Watkins represented IDEAYA, while Davis Polk advised the representatives of the several underwriters in the offering. IDEAYA Biosciences, Inc. (Nasdaq: IDYA) announced the pricing of an...
RxSight’s $50 Million At-The-Market Offering
Davis Polk advised the sales agent in the offering. RxSight, Inc. announced its shares of common stock for up to an aggregate amount of $50 million....